Tianmao Group: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement on the premium income of Guohua Life Insurance Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement of Resolutions of the Third Meeting of the 10th Board of Directors of Tianmao Group
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: 2024-065-Tianmao Industrial Group Co., Ltd. Stock Trading Abnormal Fluctuations and Serious Abnormal Fluctuations Announcement
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Semi-Annual Report Board Resolution Announcement
Tianmao Group: Announcement of the resolution of the board of supervisors on the semi-annual report
Hubei Biocause Pharmaceutical: Statement and Commitment of the Independent Director Candidate (Zhang Xiaomiao) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Statement and Commitment of Independent Director Candidate (Jiang Haihua) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Shareholder Meeting Rules (August 2024)
Hubei Biocause Pharmaceutical: Statement and Commitment of the Independent Director Candidate of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Statement and Commitment of Independent Director Candidate (Director Hu Bing) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Director, Supervisor, and Senior Management Compensation Management System (August 2024).
Hubei Biocause Pharmaceutical: Hubei Biocause Pharmaceutical Company Bylaws (August 2024)
Hubei Biocause Pharmaceutical: Announcement of the resolution of the 18th meeting of the 9th board of directors of Hubei Biocause Pharmaceutical Group.
Hubei Biocause Pharmaceutical: Rules of Procedure for the Supervisor Meeting (August 2024)
No Data